
MPR Weekly Dose Podcast Episode 35
This week we cover the latest COVID-19 developments including: reports of false negatives with Abbott's diagnostic test; the immune globulin therapy linked to recovery in multisystem inflammatory synd...
22 Mai 20208min

MPR Weekly Dose Podcast Episode 34
This week we cover the latest COVID-19 developments including a triple antiviral therapy that looks promising, Emergency Use Authorizations granted to diagnostics and critical meds, Moderna's investig...
14 Mai 20209min

MPR Weekly Dose Podcast Episode 33
This week we cover the the risk of antihypertensive med use during the pandemic; The Emergency Use Authorization for remdesivir in hospitalized patients with suspected or confirmed COVID-19; The addit...
7 Mai 20208min

MPR Weekly Dose Podcast Episode 32
There has been a lot of recent developments in possible COVID-19 treatments. I'll go over the latest status with remdesivir, hydroxychloroquine, sarilumab, and remestemcel-L, and also the treatment gu...
30 Apr 20209min

MPR Weekly Dose Podcast Episode 31
On today's podcast we run through the top COVID-19 stories including a steep rise in poison control calls; the authorization of an at-home testing kit; The hydroxychloroquine trial that's beginning so...
23 Apr 20207min

MPR Weekly Dose Podcast Episode 30
We run through the latest COVID-19 news including results from a remdesivir trial; The blood purification system OK'd for patients in the ICU; A chloroquine trial halted early due to deaths; The saliv...
17 Apr 20206min

MPR Weekly Dose Podcast Episode 29
This week we run through the latest COVID-19 news including the shortage of critical meds, The CDC U-turn on face mask recommendations, Remdesivir trial enrollment, testing for COVID-19 antibodies, an...
9 Apr 20208min

MPR Weekly Dose Podcast Episode 28
This episodes covers the latest COVID-19 news including drug shortages, a new point-of-care diagnostic tool, the role of vitamin C, misuse of non-pharmacological chloroquine, and also some big news ab...
3 Apr 20206min






















